UNSPSC 51314338: Chlorpheniramine/ephedrine/guaifenesin/hydriodic acid

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51314338

Definition

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE503. This VA Drug Class (RE503) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT/EXPECTORANT.

About UNSPSC 51314338

UNSPSC 51314338 Chlorpheniramine/ephedrine/guaifenesin/hydriodic acid is a Commodity code that in recent state and local procurement shows minimal activity matching its specific pharmaceutical formulation; the three recent opportunities tagged to this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription program capabilities, and generic multi-source pharmaceuticals and OTC products — none of which align with the code's nominal scope of a specific antihistamine-decongestant-expectorant combination medication. The mismatch suggests either miscoding by issuing bodies or that state and local procurement offices are using this code as a catch-all for pharmaceutical purchasing rather than as a specific drug formulation identifier.

Recent opportunities show activity across state health and human services agencies and cooperative purchasing vehicles rather than traditional county or municipal procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products for distribution across participating state and local facilities, including Oregon; Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023, per the posted date discrepancy in the source) for naloxone and safe drug deactivation systems with quarterly deliveries; and the Texas Health and Human Services Commission issued an RFI on April 3, 2026 to gather vendor capabilities on direct-to-manufacturer prescription fulfillment. No evidence of repeat buyers, geographic concentration, or substantial recent procurement volume under this specific code is present in the source.

Quick answers

What is UNSPSC 51314338?

UNSPSC 51314338 is Chlorpheniramine/ephedrine/guaifenesin/hydriodic acid, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51314338?

UNSPSC 51314338 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51314338

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code